Prostate cancer recurrent
RecruitingStudy Comparing Conventional Radiotherapy and PSMA-PET/CT Targeted Treatment with 18F-PSMA-1007 and Gozetotide for Prostate Cancer Recurrence After Surgery
Study Comparing Conventional Radiotherapy and PSMA-PET/CT Targeted Treatment with 18F-PSMA-1007 and Gozetotide for Prostate Cancer Recurrence After Surgery
- Disease:Prostate cancer recurrent
- Substances:Gozetotide
Sweden- Participants:18–64 years · 65+ years
- Substances:Gozetotide
- Sponsor:Karolinska University Hospital










